Novartis (NVS) and Roche executives are due to meet with Swiss government officials this week as President Donald Trump urges pharmaceutical firms to lower their prices in the US, Reuters reported Monday, citing two sources.
Economy Minister Guy Parmelin and Health Minister Elizabeth Baume-Schneider will meet with executives of the two drug makers as well as other companies, the sources told the news outlet.
Switzerland is aiming to negotiate with the US to lower the 39% tariffs announced on its exports, according to the report.
The discussions may also be about encouraging the drug makers to invest more in the US and reduce Switzerland's trade surplus with the country, which could help lower the tariffs, a source familiar with the matter told Reuters.
Novartis and Roche did not immediately reply to requests for comment from MT Newswires.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
Price: 117.82, Change: +0.97, Percent Change: +0.83
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。